William Jarnagin

Improving Outcome in Patients with Advanced Intrahepatic Cholangiocarcinoma: A Randomized Phase II Study of Gemcitabine and Oxaliplatin With or Without Regional Floxuridine (FUDR)

National Cancer Institute · U01

Contact PI · $3.3M · Sloan-Kettering Inst Can Research

Deformation Corrected Image Guided Laparoscopic Liver Surgery

National Institute of Biomedical Imaging and Bioengineering · R01

PI · $2.5M · Vanderbilt University

Clinical Translation of Deformation Compensation for Image-Guided Liver Surgery

National Cancer Institute · R01

PI · $3M · Vanderbilt University

Hepatic Arterial Flouridine and IV Bevacizumab for Primary Hepatic Malignancy

National Cancer Institute · R21

Contact PI · $624.5K · Sloan-Kettering Inst Can Research

Interrogation of Exosome-mediated Intercellular Signaling in Patients With Pancreatic Cancer

Principal investigator · Recruiting

Memorial Sloan Kettering Cancer Center

Hepatic Arterial Infusion (HAI) With Floxuridine (FUDR) and Dexamethasone (Dex) Combined With Systemic Gemcitabine and Oxaliplatin in Patients With Unresectable Intrahepatic Cholangiocarcinoma (ICC)

Principal investigator · Completed · Phase 2

Memorial Sloan Kettering Cancer Center

Feasibility of a Minimally Invasive Image-Guided Surgery System for Hepatic Procedures

Principal investigator · Completed

Pathfinder Therapeutics

Controlled Trial Comparing Nomogram-based Versus Standard Allocation of Acute Normovolemic Hemodilution (ANH) During Hepatic Resection

Principal investigator · Completed · Phase 3

Memorial Sloan Kettering Cancer Center